{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:03:23Z","timestamp":1787022203605,"version":"build-2736575974"},"update-to":[{"DOI":"10.1371\/journal.ppat.1007268","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000}}],"reference-count":107,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:00:00Z","timestamp":1535587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI110293"],"award-info":[{"award-number":["R01AI110293"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1007268","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T14:55:02Z","timestamp":1535640902000},"page":"e1007268","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Inhibition of p38 MAPK in combination with ART reduces SIV-induced immune activation and provides additional protection from immune system deterioration"],"prefix":"10.1371","volume":"14","author":[{"given":"Omkar","family":"Chaudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3708-3810","authenticated-orcid":true,"given":"Felipe","family":"Lelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Linz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Veazey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5366-7728","authenticated-orcid":true,"given":"Anna","family":"Aldovini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,8,30]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1203\/00006450-199711000-00018","article-title":"Apoptosis of CD4+ and CD8+ T cells isolated immediately ex vivo correlates with disease severity in human immunodeficiency virus type 1 infection","volume":"42","author":"MF Cotton","year":"1997","journal-title":"Pediatr Res"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.4049\/jimmunol.156.9.3509","article-title":"Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression","volume":"156","author":"ML Gougeon","year":"1996","journal-title":"J Immunol"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/sj.leu.2402028","article-title":"Using death to one's advantage: HIV modulation of apoptosis","volume":"15","author":"TM Ross","year":"2001","journal-title":"Leukemia"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1128\/JVI.74.3.1209-1223.2000","article-title":"Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection","volume":"74","author":"LA Chakrabarti","year":"2000","journal-title":"J Virol"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1128\/JVI.72.6.4623-4632.1998","article-title":"Loss of CD4+ T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis","volume":"72","author":"IC Davis","year":"1998","journal-title":"J Virol"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"506","DOI":"10.4049\/jimmunol.166.1.506","article-title":"Relative resistance in the development of T cell anergy in CD4+ T cells from simian immunodeficiency virus disease-resistant sooty mangabeys","volume":"166","author":"P Bostik","year":"2001","journal-title":"J Immunol"},{"issue":"1\u20132","key":"ref7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0165-2478(96)02556-4","article-title":"Immunological and virological studies of natural SIV infection of disease-resistant nonhuman primates","volume":"51","author":"F Villinger","year":"1996","journal-title":"Immunol Lett"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1128\/JVI.79.7.4043-4054.2005","article-title":"Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts","volume":"79","author":"G Silvestri","year":"2005","journal-title":"J Virol"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1074-7613(03)00060-8","article-title":"Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia","volume":"18","author":"G Silvestri","year":"2003","journal-title":"Immunity"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.1128\/JVI.70.9.6502-6507.1996","article-title":"Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis","volume":"70","author":"A Ehret","year":"1996","journal-title":"J Virol"},{"issue":"1\u20132","key":"ref11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0165-2478(96)02554-0","article-title":"Immune strategies utilized by lentivirus infected chimpanzees to resist progression to AIDS","volume":"51","author":"J Heeney","year":"1996","journal-title":"Immunol Lett"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1086\/515378","article-title":"Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term nonprogressors","volume":"178","author":"TJ Liegler","year":"1998","journal-title":"J Infect Dis"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2249.2000.01375.x","article-title":"Apoptosis and apoptosis-associated perturbations of peripheral blood lymphocytes during HIV infection: comparison between AIDS patients and asymptomatic long-term non-progressors","volume":"122","author":"S Moretti","year":"2000","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/COH.0000000000000105","article-title":"Neuropathogenesis of HIV-associated neurocognitive disorders: roles for immune activation, HIV blipping and viral tropism","volume":"9","author":"MF Chen","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.idc.2014.05.003","article-title":"HIV-related metabolic comorbidities in the current ART era","volume":"28","author":"AH Warriner","year":"2014","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/QCO.0000000000000117","article-title":"Emerging concepts on the use of antiretroviral therapy in older adults living with HIV infection","volume":"28","author":"A Winston","year":"2015","journal-title":"Curr Opin Infect Dis"},{"issue":"18","key":"ref17","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1097\/QAD.0000000000001677","article-title":"Reducing medical comorbidities associated with long-term HIV infection: beyond optimizing antiretroviral therapy regimens","volume":"31","author":"NJ Dharan","year":"2017","journal-title":"AIDS"},{"issue":"13","key":"ref18","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.1128\/JVI.00073-11","article-title":"An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses","volume":"85","author":"FO Pettersen","year":"2011","journal-title":"Journal of virology"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3858\/emm.2011.43.12.077","article-title":"Rottlerin enhances IL-1beta-induced COX-2 expression through sustained p38 MAPK activation in MDA-MB-231 human breast cancer cells","volume":"43","author":"EJ Park","year":"2011","journal-title":"Experimental & molecular medicine"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"e0176527","DOI":"10.1371\/journal.pone.0176527","article-title":"Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial","volume":"12","author":"C Prebensen","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1172\/JCI60612","article-title":"PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques","volume":"122","author":"R Dyavar Shetty","year":"2012","journal-title":"The Journal of clinical investigation"},{"issue":"23","key":"ref22","doi-asserted-by":"crossref","first-page":"11536","DOI":"10.1128\/JVI.00485-08","article-title":"Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism","volume":"82","author":"K Muthumani","year":"2008","journal-title":"Journal of virology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2119\/molmed.2012.00103","article-title":"p38 Mitogen-activated protein kinase\/signal transducer and activator of transcription-3 pathway signaling regulates expression of inhibitory molecules in T cells activated by HIV-1-exposed dendritic cells","volume":"18","author":"KF Che","year":"2012","journal-title":"Molecular medicine"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/infdis\/jis643","article-title":"Reduced inflammation and lymphoid tissue immunopathology in rhesus macaques receiving anti-tumor necrosis factor treatment during primary simian immunodeficiency virus infection","volume":"207","author":"B Tabb","year":"2013","journal-title":"The Journal of infectious diseases"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"e1003530","DOI":"10.1371\/journal.ppat.1003530","article-title":"Blocking TLR7- and TLR9-mediated IFN-alpha Production by Plasmacytoid Dendritic Cells Does Not Diminish Immune Activation in Early SIV Infection","volume":"9","author":"M Kader","year":"2013","journal-title":"PLoS pathogens"},{"issue":"24","key":"ref26","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1182\/blood-2012-02-411496","article-title":"Treatment of SIV-infected sooty mangabeys with a type-I IFN agonist results in decreased virus replication without inducing hyperimmune activation","volume":"119","author":"TH Vanderford","year":"2012","journal-title":"Blood"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1172\/JCI81400","article-title":"Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques","volume":"125","author":"L Micci","year":"2015","journal-title":"J Clin Invest"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1101\/sqb.2013.78.020321","article-title":"The IRF family transcription factors at the interface of innate and adaptive immune responses","volume":"78","author":"H Ikushima","year":"2013","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri1865","article-title":"The many paths to p38 mitogen-activated protein kinase activation in the immune system","volume":"6","author":"JD Ashwell","year":"2006","journal-title":"Nature reviews Immunology"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-065X.2008.00744.x","article-title":"Regulation of the immune response by stress-activated protein kinases","volume":"228","author":"M Rincon","year":"2009","journal-title":"Immunological reviews"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s11481-011-9260-0","article-title":"Mitogen-activated protein kinase p38 in HIV infection and associated brain injury","volume":"6","author":"KE Medders","journal-title":"J Neuroimmune Pharmacol"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0962-8924(99)01709-2","article-title":"Association of STATs with relatives and friends","volume":"10","author":"M Chatterjee-Kishore","year":"2000","journal-title":"Trends Cell Biol"},{"issue":"42","key":"ref33","doi-asserted-by":"crossref","first-page":"30127","DOI":"10.1074\/jbc.274.42.30127","article-title":"Activation of the p38 mitogen-activated protein kinase by type I interferons","volume":"274","author":"S Uddin","year":"1999","journal-title":"J Biol Chem"},{"issue":"20","key":"ref34","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1093\/emboj\/18.20.5601","article-title":"p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons","volume":"18","author":"KC Goh","year":"1999","journal-title":"EMBO J"},{"issue":"36","key":"ref35","doi-asserted-by":"crossref","first-page":"27634","DOI":"10.1074\/jbc.M003170200","article-title":"The Rac1\/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins","volume":"275","author":"S Uddin","year":"2000","journal-title":"J Biol Chem"},{"issue":"30","key":"ref36","doi-asserted-by":"crossref","first-page":"27772","DOI":"10.1074\/jbc.M301364200","article-title":"Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons","volume":"278","author":"F Lekmine","year":"2003","journal-title":"J Biol Chem"},{"issue":"30","key":"ref37","doi-asserted-by":"crossref","first-page":"28570","DOI":"10.1074\/jbc.M011685200","article-title":"The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells","volume":"276","author":"IA Mayer","year":"2001","journal-title":"J Biol Chem"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1182\/blood-2009-04-216770","article-title":"TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFN","volume":"114","author":"J Di Domizio","year":"2009","journal-title":"Blood"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1128\/JVI.80.1.226-235.2006","article-title":"Identification of a novel pathway essential for the immediate-early, interferon-independent antiviral response to enveloped virions","volume":"80","author":"RS Noyce","year":"2006","journal-title":"J Virol"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0002-9440(10)63125-2","article-title":"Dysregulation of mitogen-activated protein kinase signaling pathways in simian immunodeficiency virus encephalitis","volume":"164","author":"SA Barber","year":"2004","journal-title":"Am J Pathol"},{"issue":"19","key":"ref41","doi-asserted-by":"crossref","first-page":"9214","DOI":"10.1128\/JVI.74.19.9214-9221.2000","article-title":"Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes","volume":"74","author":"O Kutsch","year":"2000","journal-title":"J Virol"},{"issue":"7","key":"ref42","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/glia.20801","article-title":"Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes","volume":"57","author":"R Williams","year":"2009","journal-title":"Glia"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"e5709","DOI":"10.1371\/journal.pone.0005709","article-title":"HIV-1 Tat co-operates with IFN-gamma and TNF-alpha to increase CXCL10 in human astrocytes","volume":"4","author":"R Williams","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4049\/jimmunol.177.1.702","article-title":"Inhibition of mixed lineage kinase 3 prevents HIV-1 Tat-mediated neurotoxicity and monocyte activation","volume":"177","author":"Z Sui","year":"2006","journal-title":"J Immunol"},{"issue":"14","key":"ref45","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.1128\/JVI.02616-06","article-title":"Human and simian immunodeficiency virus-mediated upregulation of the apoptotic factor TRAIL occurs in antigen-presenting cells from AIDS-susceptible but not from AIDS-resistant species","volume":"81","author":"N Kim","year":"2007","journal-title":"J Virol"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"e1001103","DOI":"10.1371\/journal.ppat.1001103","article-title":"Association of Tat with promoters of PTEN and PP2A subunits is key to transcriptional activation of apoptotic pathways in HIV-infected CD4+ T cells","volume":"6","author":"N Kim","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref47","article-title":"Tat engagement of p38 MAP kinase and IRF7 pathways leads to activation of Interferon-stimulated genes in antigen presenting cells","author":"N Kim","year":"2013","journal-title":"Blood"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/infdis\/jir214","article-title":"Soluble CD163 made by monocyte\/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy","volume":"204","author":"TH Burdo","year":"2011","journal-title":"The Journal of infectious diseases"},{"issue":"8","key":"ref49","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.molmed.2009.06.005","article-title":"p38(MAPK): stress responses from molecular mechanisms to therapeutics","volume":"15","author":"LR Coulthard","year":"2009","journal-title":"Trends in molecular medicine"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1124\/jpet.109.158329","article-title":"Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation","volume":"331","author":"HR Hope","year":"2009","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-3565(24)35155-9","article-title":"RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase","volume":"291","author":"SA Wadsworth","year":"1999","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4155\/bio.11.290","article-title":"Critical review of p38 MAP kinase inhibitors: a bioanalytical perspective","volume":"4","author":"P Wong","year":"2012","journal-title":"Bioanalysis"},{"issue":"27","key":"ref53","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1021\/bi900655f","article-title":"Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804","volume":"48","author":"L Xing","year":"2009","journal-title":"Biochemistry"},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1378\/chest.10-1914","article-title":"p38 mitogen-activated protein kinase pathways in asthma and COPD","volume":"139","author":"KF Chung","year":"2011","journal-title":"Chest"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0022-3565(25)21307-6","article-title":"Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein\/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function","volume":"279","author":"AM Badger","year":"1996","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1742-2094-4-21","article-title":"A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model","volume":"4","author":"L Munoz","year":"2007","journal-title":"Journal of neuroinflammation"},{"issue":"10","key":"ref57","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ejpain.2011.04.005","article-title":"Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury","volume":"15","author":"P Anand","year":"2011","journal-title":"European journal of pain"},{"issue":"Suppl. 54","key":"ref58","article-title":"A randomized, placebo controlled trial of 6 weeks' treatment wth a novel oral p38 inhibitor in patients with COPD","volume":"36","author":"W MacNee","year":"2010","journal-title":"Eur Respir J"},{"issue":"S1","key":"ref59","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1754-3207(11)70625-3","article-title":"A two period four treatment crossover trial of PH-797804 alone or with NAproxen in subject with painful knee osteoarthritis","volume":"5","author":"P Sanders","year":"2012","journal-title":"European Journal of Pain Supplements"},{"issue":"8","key":"ref60","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/thoraxjnl-2012-202744","article-title":"Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial","volume":"68","author":"W MacNee","year":"2013","journal-title":"Thorax"},{"issue":"7109","key":"ref61","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"CL Day","year":"2006","journal-title":"Nature"},{"issue":"4","key":"ref62","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1089\/aid.2015.0163","article-title":"Plasma Cytokine Levels in Chronic Asymptomatic HIV-1 Subtype C Infection as an Indicator of Disease Progression in Botswana: A Retrospective Case Control Study","volume":"32","author":"T Iketleng","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"10","key":"ref63","doi-asserted-by":"crossref","first-page":"e46143","DOI":"10.1371\/journal.pone.0046143","article-title":"Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection","volume":"7","author":"AS Liovat","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"ref64","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1089\/aid.2011.0144","article-title":"Increased levels of circulating cytokines with HIV-related immunosuppression","volume":"28","author":"FM Shebl","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"ref65","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/infdis\/jiu125","article-title":"Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease","volume":"210","author":"CL Shive","year":"2014","journal-title":"J Infect Dis"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1074\/jbc.M113.520213","article-title":"Structural basis for inflammation-driven shedding of CD163 ectodomain and tumor necrosis factor-alpha in macrophages","volume":"289","author":"A Etzerodt","year":"2014","journal-title":"J Biol Chem"},{"issue":"8","key":"ref67","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/infdis\/jiw263","article-title":"Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals","volume":"214","author":"TB Knudsen","year":"2016","journal-title":"J Infect Dis"},{"issue":"5779","key":"ref68","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1126\/science.1124226","article-title":"Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys","volume":"312","author":"NL Letvin","year":"2006","journal-title":"Science"},{"issue":"7","key":"ref69","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1182\/blood-2008-05-159301","article-title":"Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections","volume":"112","author":"JM Brenchley","year":"2008","journal-title":"Blood"},{"issue":"4","key":"ref70","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/mi.2008.14","article-title":"Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques","volume":"1","author":"V Cecchinato","year":"2008","journal-title":"Mucosal Immunol"},{"issue":"2","key":"ref71","doi-asserted-by":"crossref","first-page":"e1000295","DOI":"10.1371\/journal.ppat.1000295","article-title":"Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection","volume":"5","author":"D Favre","year":"2009","journal-title":"PLoS Pathog"},{"issue":"9","key":"ref72","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.4049\/jimmunol.1001801","article-title":"Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals","volume":"185","author":"SN Gordon","year":"2010","journal-title":"J Immunol"},{"issue":"2","key":"ref73","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clim.2011.02.008","article-title":"Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors","volume":"139","author":"M Salgado","year":"2011","journal-title":"Clin Immunol"},{"issue":"3","key":"ref74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nm1710","article-title":"IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia","volume":"14","author":"SJ Aujla","year":"2008","journal-title":"Nat Med"},{"issue":"4","key":"ref75","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/mi.2010.22","article-title":"IL-22 defines a novel immune pathway of antifungal resistance","volume":"3","author":"A De Luca","year":"2010","journal-title":"Mucosal Immunol"},{"issue":"4","key":"ref76","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/infdis\/jiu126","article-title":"Enteric mucosa integrity in the presence of a preserved innate interleukin 22 compartment in HIV type 1-treated individuals","volume":"210","author":"SM Fernandes","year":"2014","journal-title":"J Infect Dis"},{"issue":"7","key":"ref77","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1084\/jem.20082683","article-title":"STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing","volume":"206","author":"G Pickert","year":"2009","journal-title":"J Exp Med"},{"issue":"5","key":"ref78","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ni.2025","article-title":"Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22","volume":"12","author":"GF Sonnenberg","year":"2011","journal-title":"Nat Immunol"},{"issue":"2","key":"ref79","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"K Wolk","year":"2004","journal-title":"Immunity"},{"issue":"3","key":"ref80","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm1720","article-title":"Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens","volume":"14","author":"Y Zheng","year":"2008","journal-title":"Nat Med"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"852418","DOI":"10.1155\/2013\/852418","article-title":"Loss and dysregulation of Th17 cells during HIV infection","volume":"2013","author":"SL Bixler","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"11511","DOI":"10.1038\/srep11511","article-title":"Th17 and Th17\/Treg ratio at early HIV infection associate with protective HIV-specific CD8(+) T-cell responses and disease progression","volume":"5","author":"J Falivene","year":"2015","journal-title":"Sci Rep"},{"issue":"2","key":"ref83","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/COH.0b013e328335c0c1","article-title":"Th17 and regulatory T cells: implications for AIDS pathogenesis","volume":"5","author":"B Kanwar","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"issue":"7661","key":"ref84","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature22984","article-title":"Addendum: Immune clearance of highly pathogenic SIV infection","volume":"547","author":"SG Hansen","year":"2017","journal-title":"Nature"},{"issue":"18","key":"ref85","doi-asserted-by":"crossref","first-page":"E3659","DOI":"10.1073\/pnas.1617961114","article-title":"Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART","volume":"114","author":"A Wiegand","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"ref86","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3851\/IMP2273","article-title":"HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy","volume":"17","author":"C Goujard","year":"2012","journal-title":"Antivir Ther"},{"issue":"3","key":"ref87","doi-asserted-by":"crossref","first-page":"e1001196","DOI":"10.1371\/journal.pmed.1001196","article-title":"No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial","volume":"9","author":"ML Grijsen","year":"2012","journal-title":"PLoS Med"},{"issue":"5","key":"ref88","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.tim.2016.01.006","article-title":"HIV-1 Reservoirs During Suppressive Therapy","volume":"24","author":"K Barton","year":"2016","journal-title":"Trends Microbiol"},{"issue":"15","key":"ref89","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1073\/pnas.95.15.8869","article-title":"Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection","volume":"95","author":"TW Chun","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"ref90","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1073\/pnas.0903022106","article-title":"High frequencies of resting CD4+ T cells containing integrated viral DNA are found in rhesus macaques during acute lentivirus infections","volume":"106","author":"Y Nishimura","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7512","key":"ref91","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature13594","article-title":"Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys","volume":"512","author":"JB Whitney","year":"2014","journal-title":"Nature"},{"issue":"2","key":"ref92","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1310\/hct1402-61","article-title":"Immune Activation While on Potent Antiretroviral Therapy Can Predict Subsequent CD4+ T-Cell Increases Through 15 Years of Treatment","volume":"14","author":"X Zhang","year":"2013","journal-title":"HIV clinical trials"},{"issue":"14","key":"ref93","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/QAD.0b013e32828e4e27","article-title":"The prevalence and incidence of neurocognitive impairment in the HAART era","volume":"21","author":"KR Robertson","year":"2007","journal-title":"AIDS"},{"issue":"2","key":"ref94","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/13550280290049615","article-title":"HIV-associated cognitive impairment before and after the advent of combination therapy","volume":"8","author":"N Sacktor","year":"2002","journal-title":"Journal of neurovirology"},{"issue":"5","key":"ref95","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1172\/JCI0214522","article-title":"Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy","volume":"109","author":"GP Rizzardi","year":"2002","journal-title":"The Journal of clinical investigation"},{"issue":"4","key":"ref96","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00126334-200204010-00005","article-title":"Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantation","volume":"29","author":"LH Calabrese","year":"2002","journal-title":"Journal of acquired immune deficiency syndromes"},{"issue":"9","key":"ref97","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1086\/651664","article-title":"The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection","volume":"201","author":"M Markowitz","year":"2010","journal-title":"The Journal of infectious diseases"},{"issue":"2","key":"ref98","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1086\/514054","article-title":"Cyclosporin A modulation of early virologic and immunologic events during primary simian immunodeficiency virus infection in rhesus monkeys","volume":"176","author":"LN Martin","year":"1997","journal-title":"The Journal of infectious diseases"},{"issue":"12","key":"ref99","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"PM Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"10105","key":"ref100","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"PM Ridker","year":"2017","journal-title":"Lancet"},{"issue":"11","key":"ref101","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/cid\/civ171","article-title":"Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA","volume":"60","author":"M Laanani","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"16","key":"ref102","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1128\/JVI.00895-07","article-title":"Mamu-B*08-positive macaques control simian immunodeficiency virus replication","volume":"81","author":"JT Loffredo","year":"2007","journal-title":"J Virol"},{"issue":"16","key":"ref103","doi-asserted-by":"crossref","first-page":"9029","DOI":"10.1128\/JVI.77.16.9029-9040.2003","article-title":"Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses","volume":"77","author":"DH O'Connor","year":"2003","journal-title":"J Virol"},{"issue":"4","key":"ref104","first-page":"262","article-title":"Considerations in the development of nonhuman primate models of combination antiretroviral therapy for studies of AIDS virus suppression, residual virus, and curative strategies","volume":"8","author":"GQ Del Prete","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"issue":"9","key":"ref105","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.4049\/jimmunol.1401222","article-title":"Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa","volume":"193","author":"GH Mylvaganam","year":"2014","journal-title":"J Immunol"},{"issue":"21","key":"ref106","doi-asserted-by":"crossref","first-page":"10187","DOI":"10.1128\/JVI.75.21.10187-10199.2001","article-title":"Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment","volume":"75","author":"JD Lifson","year":"2001","journal-title":"J Virol"},{"issue":"2","key":"ref107","doi-asserted-by":"crossref","first-page":"e1005412","DOI":"10.1371\/journal.ppat.1005412","article-title":"Loss of Function of Intestinal IL-17 and IL-22 Producing Cells Contributes to Inflammation and Viral Persistence in SIV-Infected Rhesus Macaques","volume":"12","author":"ES Ryan","year":"2016","journal-title":"PLoS Pathog"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1007268","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1007268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T14:23:46Z","timestamp":1751811826000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1007268"}},"subtitle":[],"editor":[{"given":"Susan R.","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,30]]},"references-count":107,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1007268","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,30]]}}}